Charles Swanton Selected Research

Charles Swanton Research Topics

Disease

125	Neoplasms (Cancer) 11/2022 - 11/2004
25	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2006
16	Lung Neoplasms (Lung Cancer) 09/2020 - 01/2013
11	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 07/2009
11	Chromosomal Instability (Chromosome Stability) 10/2021 - 04/2006
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2006
9	Melanoma (Melanoma, Malignant) 01/2021 - 03/2013
7	COVID-19 01/2022 - 01/2020
7	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 04/2006
6	Disease Progression 11/2022 - 01/2006
6	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2010
5	Adenocarcinoma of Lung 01/2022 - 11/2015
3	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 01/2012
3	Genomic Instability 01/2021 - 10/2012
3	Infections 01/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 05/2009 - 06/2007
2	Residual Neoplasm 01/2022 - 06/2007
2	Bites and Stings (Sting) 01/2021 - 01/2018
2	Carcinogenesis 01/2021 - 03/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 11/2013
2	Glioma (Gliomas) 05/2017 - 03/2013
2	Aneuploidy (Aneuploid) 01/2017 - 01/2017
2	Triple Negative Breast Neoplasms 12/2016 - 04/2010
2	Polyploidy 02/2012 - 06/2007
1	Microsatellite Instability 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Epilepsy (Aura) 01/2021
1	Malignant Mesothelioma 01/2021
1	Cytokine Release Syndrome 01/2021

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2010
20	Pharmaceutical PreparationsIBA 01/2020 - 06/2007
15	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2004
15	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 05/2011
9	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2006
8	RNA (Ribonucleic Acid)IBA 11/2022 - 04/2012
8	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2016
8	Estrogen ReceptorsIBA 09/2014 - 05/2009
7	AntibodiesIBA 01/2022 - 01/2017
6	Biological ProductsIBA 01/2022 - 05/2011
6	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2011
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021 - 12/2013
5	AntigensIBA 01/2021 - 12/2013
5	PlatinumIBA 01/2021 - 10/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2012 - 06/2007
4	Phosphotransferases (Kinase)IBA 11/2020 - 08/2007
4	Tamoxifen FDA LinkGeneric 04/2013 - 02/2008
4	Taxoids (Taxanes)IBA 11/2010 - 04/2006
3	Circulating Tumor DNAIBA 10/2021 - 02/2016
3	EnzymesIBA 10/2021 - 07/2015
3	pertuzumabIBA 01/2021 - 01/2018
3	human ERBB2 proteinIBA 01/2018 - 11/2013
3	Cytotoxins (Cytolysins)IBA 05/2016 - 06/2007
3	taxaneIBA 06/2013 - 04/2006
3	CeramidesIBA 02/2012 - 06/2007
2	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
2	Cell-Free Nucleic AcidsIBA 06/2022 - 12/2017
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	VaccinesIBA 12/2021 - 12/2021
2	Neutralizing AntibodiesIBA 12/2021 - 12/2021
2	CarcinogensIBA 12/2021 - 10/2014
2	NivolumabIBA 11/2021 - 10/2021
2	CytosineIBA 10/2021 - 07/2015
2	cyclopropapyrroloindoleIBA 01/2021 - 01/2020
2	SteroidsIBA 01/2021 - 08/2017
2	Cyclin DIBA 01/2021 - 01/2004
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2004
2	ChromatinIBA 01/2021 - 01/2017
2	Carisoprodol (Soma)FDA LinkGeneric 01/2021 - 10/2020
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 06/2012
2	IgG Receptors (Fc gamma RI)IBA 01/2018 - 01/2017
2	NucleotidesIBA 10/2015 - 10/2012
2	TOR Serine-Threonine KinasesIBA 04/2015 - 11/2011
2	AnthracyclinesIBA 11/2010 - 11/2006
2	Estrogen Receptor Modulators (Antiestrogen)IBA 02/2010 - 02/2008
2	Carboplatin (JM8)FDA LinkGeneric 10/2009 - 05/2009
1	SolutionsIBA 06/2022
1	atezolizumabIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	B7-H1 AntigenIBA 10/2021
1	pembrolizumabIBA 10/2021
1	AsbestosIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	BNT162 VaccineIBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	CytokinesIBA 01/2021
1	UbiquitinIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021

Therapy/Procedure

70	Therapeutics 01/2022 - 11/2004
15	Immunotherapy 01/2022 - 07/2009
12	Drug Therapy (Chemotherapy) 01/2021 - 06/2007
11	Precision Medicine 10/2021 - 03/2012
3	Neoadjuvant Therapy 10/2021 - 04/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 10/2016
2	Adjuvant Chemotherapy 01/2017 - 02/2012
2	Castration 01/2017 - 01/2012
1	Long-Term Care 01/2021